🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Florida › Tampa

Kliničke studije za Akutna mijeloidna leukemija u gradu Tampa, FL

30 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Tampa i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 65 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06552416

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Тражи се учесникФаза 3
  • Moffitt Cancer Center & Research Institute, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 3
  • Moffit Cancer center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • Moffitt Cancer Center-International Plaza, Tampa
  • Moffitt Cancer Center - McKinley Campus, Tampa
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Тражи се учесникФаза 3
  • Moffitt Cancer Center, Tampa
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

Study of REM-422 in Patients With AML or Higher Risk MDS

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Тражи се учесникФаза 1/2
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 1/2
  • Moffitt Cancer Center and Research Institute Hospital, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06969430

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 2/3
  • Moffitt Cancer Center /ID# 279192, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07581002

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Тражи се учесникФаза 3
  • Clinical Trial Site, Tampa
Узраст 12 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07211958

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06533761

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Тражи се учесникФаза 2
  • Moffitt Cancer Center, Tampa
Узраст од 1 до 60 · Оба пола · Ажурирано 20. 10. 2026. · NCT03970096

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Тражи се учесникФаза 1
  • H Lee Moffitt Cancer Center and Research Institute, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06846606

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616636

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • Tampa General Hospital, Tampa
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

Тражи се учесникФаза 1/2
  • Tampa General Hospital, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT04771130

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Тражи се учесникФаза 1/2
  • Moffitt Cancer Center, Tampa
Узраст 12 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Тражи се учесникФаза 1
  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06656494

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Тражи се учесникФаза 2
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

Тражи се учесникФаза 2
  • Moffitt Cancer Center, Tampa
Узраст од 18 до 80 · Оба пола · Ажурирано 1. 4. 2026. · NCT06660368

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Тражи се учесникФаза 1/2
  • Moffitt Cancer Center, Tampa
Узраст 12 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT04988555

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 12 и старији · Оба пола · Ажурирано 16. 3. 2026. · NCT06994676

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст од 18 до 70 · Оба пола · Ажурирано 27. 2. 2026. · NCT05558124

Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD

Тражи се учесникФаза 2
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 27. 2. 2026. · NCT06511882

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Тражи се учесникФаза 1
  • Moffitt, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 9. 2. 2026. · NCT06950034

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Тражи се учесникФаза 1
  • Moffitt Cancer Center, Tampa
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2025. · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Тражи се учесникЗдраве особе су добродошле
  • Moffitt Cancer Center, Tampa
Узраст од 18 до 120 · Оба пола · Ажурирано 25. 7. 2025. · NCT05237258

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Tampa

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.